Assignee
ABBVIE INC
US·482 granted patents·582 pending applications·3,910 citations·filing 2008–2025
Top patents by PatentIndex Score
1,064 records- 0198US11787815B1Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 17, 2023·8 cites·10 claims
- 0298US11780847B1Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 10, 2023·7 cites·8 claims
- 0398US11718627B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Aug 8, 2023·9 cites·30 claims
- 0498US11535625B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Dec 27, 2022·19 cites·20 claims
- 0598US11535624B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Dec 27, 2022·19 cites·5 claims
- 0698US11535626B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1 carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Dec 27, 2022·18 cites·20 claims
- 0798US11524964B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Dec 13, 2022·21 cites·10 claims
- 0898US11512092B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Nov 29, 2022·21 cites·22 claims
- 0998US11198697B1Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2021·Granted Dec 14, 2021·29 cites·30 claims
- 1098US11186584B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2021·Granted Nov 30, 2021·28 cites·23 claims
- 1198US10995095B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereofABBVIE INC·Filed 2019·Granted May 4, 2021·28 cites·9 claims
- 1298US10981924B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2020·Granted Apr 20, 2021·33 cites·25 claims
- 1398US10981923B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[l,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2020·Granted Apr 20, 2021·32 cites·30 claims
- 1498US10730883B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2020·Granted Aug 4, 2020·35 cites·5 claims
- 1598US10597400B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereofABBVIE INC·Filed 2019·Granted Mar 24, 2020·36 cites·24 claims
- 1698US10550126B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2018·Granted Feb 4, 2020·37 cites·9 claims
- 1798US10519164B2Processes for the preparation of (3S,4R)-3,ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2019·Granted Dec 31, 2019·35 cites·11 claims
- 1898US10344036B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-#a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-#carboxamide and solid state forms thereofABBVIE INC·Filed 2018·Granted Jul 9, 2019·35 cites·30 claims
- 1998US10202394B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2018·Granted Feb 12, 2019·37 cites·30 claims
- 2098US10202393B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2018·Granted Feb 12, 2019·37 cites·30 claims
- 2198US10017517B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluorethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2018·Granted Jul 10, 2018·41 cites·30 claims
- 2298US9963459B1Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-alpla]pyrrolo[2,3-e]-pyrazin-8-YL)-N-(2,2,2-Trifluoroethyl)pyrrol and solid state forms thereofABBVIE INC·Filed 2017·Granted May 8, 2018·42 cites·30 claims
- 2398US9951080B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-alpha]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2017·Granted Apr 24, 2018·41 cites·30 claims
- 2498US9359434B2Cell culture methods to reduce acidic speciesABBVIE INC·Filed 2015·Granted Jun 7, 2016·35 cites·30 claims
- 2598US9284371B2Methods of producing adalimumabABBVIE INC·Filed 2015·Granted Mar 15, 2016·29 cites·30 claims
- 2698US9241873B2Medicine container, method of assembling the container, and method of dispensing the medicine from the containerABBVIE INC·Filed 2014·Granted Jan 26, 2016·32 cites·20 claims
- 2797US12091415B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Sep 17, 2024·3 cites·3 claims
- 2897US12077545B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Sep 3, 2024·2 cites·11 claims
- 2997US11773105B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]- pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 3, 2023·7 cites·30 claims
- 3097US11767326B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Sep 26, 2023·7 cites·24 claims
- 3197US11680069B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted Jun 20, 2023·6 cites·30 claims
- 3297US11661425B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2022·Granted May 30, 2023·9 cites·30 claims
- 3397USRE47221ETricyclic compoundsABBVIE INC·Filed 2017·Granted Feb 5, 2019·42 cites·14 claims
- 3497US9365579B2Tricyclic compoundsABBVIE INC·Filed 2015·Granted Jun 14, 2016·50 cites·15 claims
- 3597US9365645B1Methods for controlling the galactosylation profile of recombinantly-expressed proteinsABBVIE INC·Filed 2016·Granted Jun 14, 2016·18 cites·30 claims
- 3697US9334319B2Low acidic species compositionsABBVIE INC·Filed 2013·Granted May 10, 2016·29 cites·61 claims
- 3797US9290568B2Methods to control protein heterogeneityABBVIE INC·Filed 2015·Granted Mar 22, 2016·19 cites·30 claims
- 3897US9266949B2Low acidic species compositions and methods for producing and using the sameABBVIE INC·Filed 2014·Granted Feb 23, 2016·25 cites·30 claims
- 3997US9234033B2Methods to control protein heterogeneityABBVIE INC·Filed 2015·Granted Jan 12, 2016·17 cites·30 claims
- 4097US9200070B2Low acidic species compositions and methods for producing and using the sameABBVIE INC·Filed 2015·Granted Dec 1, 2015·21 cites·30 claims
- 4197US9200069B2Low acidic species compositions and methods for producing and using the sameABBVIE INC·Filed 2015·Granted Dec 1, 2015·18 cites·30 claims
- 4297US9174982B2Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseasesABBVIE INC·Filed 2013·Granted Nov 3, 2015·38 cites·7 claims
- 4397US9150645B2Cell culture methods to reduce acidic speciesABBVIE INC·Filed 2013·Granted Oct 6, 2015·40 cites·55 claims
- 4497US9085618B2Low acidic species compositions and methods for producing and using the sameABBVIE INC·Filed 2013·Granted Jul 21, 2015·38 cites·30 claims
- 4597US8906646B2Fed-batch method of making human anti-TNF-alpha antibodyABBVIE INC·Filed 2014·Granted Dec 9, 2014·44 cites·28 claims
- 4697US8686136B2Apoptosis promotersABBVIE INC·Filed 2012·Granted Apr 1, 2014·20 cites·2 claims
- 4796US11976077B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therofABBVIE INC·Filed 2023·Granted May 7, 2024·6 cites·24 claims
- 4896US11795175B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 24, 2023·8 cites·24 claims
- 4996US11780848B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 10, 2023·7 cites·18 claims
- 5096US11773106B2Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereofABBVIE INC·Filed 2023·Granted Oct 3, 2023·7 cites·15 claims
Showing the top 50 of 1,064 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →